Trial Profile
Post Marketing Surveillance of Efficacy and Safety of Cilostazol for the Indication of CSPS.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2016
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary)
- Indications Cerebral infarction; Embolism and thrombosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Korea Otsuka Pharmaceutical
- 30 Dec 2009 New trial record